Abiopharma

🔍 Khurana Akash (Executive)

Company: WESCO INTERNATIONAL INC (WCC)

Report Date: 2026-08-17

Detailed Transactions and Holdings:

• Sold 1,560 shares of Common Stock at $366.1 per share (Direct)
  Date: 2026-08-17 | Code: S | equity_swap_involved: false | shares_owned_after: 29,243.64 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,480 shares of Common Stock at $367.13 per share (Direct)
  Date: 2026-08-17 | Code: S | equity_swap_involved: false | shares_owned_after: 27,763.64 | transaction_form_type: 4 | Footnotes: F2
• Sold 360 shares of Common Stock at $368.27 per share (Direct)
  Date: 2026-08-17 | Code: S | equity_swap_involved: false | shares_owned_after: 27,403.64 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: Represents weighted average sale price. These shares were sold in multiple transactions at prices ranging from $365.55 - $366.37. Upon request by the SEC, the Issuer or a stockholder of the Issuer, complete information regarding the number of shares sold at each price within the range will be provided.
• F2: Represents weighted average sale price. These shares were sold in multiple transactions at prices ranging from $366.63 - $367.38. Upon request by the SEC, the Issuer or a stockholder of the Issuer, complete information regarding the number of shares sold at each price within the range will be provided.
• F3: Represents weighted average sale price. These shares were sold in multiple transactions at prices ranging from $367.99 - $368.58. Upon request by the SEC, the Issuer or a stockholder of the Issuer, complete information regarding the number of shares sold at each price within the range will be provided.